Achaogen, which is developing antibacterials for the treatment of multi-drug resistant infections, announced terms for its IPO on Tuesday. The South San Francisco, CA-based company plans to raise $65 million by offering 5 million shares at a price range of $12 to $14.
Help employers find you! Check out all the jobs and post your resume.
